THOR MEDICAL ASA

Operating

Thor Medical | Alpha emitters for cancer therapy

Thor Medical will become the world leading supplier of alpha emitters for cancer therapy.

Levere alfaemittere til leverandører og utviklere av innovative legemidler som retter seg mot indikasjoner med høyt udekket medisinsk behov, inkludert eventuelle medisinske produkter og utstyr, og å drive virksomhet relatert til dette eller forbundet med dette.

Utvikling, produksjon, markedsføring og salg av medisinske produkter og utstyr.

Organization

CEO: JC
Jasper Cornelius Kurth1984
Chairman of the board: JA
John Andersen1967
Years since formation: 16 years; since Jul 7, 2009
Type: Public limited company
VAT registered: Yes
Number of employees: 17

Ownership

Number of shares and share classes: 280,492,395; 1 share class
Total number of shareholders: 13920; 641 companies, 13,279 persons
Belongs to group of

Financials

Annual total result 2024: -40,593,000; NOK
Total equity 2024: 341,463,000; NOK

Last update: Oct 14, 2025

Management

Management / administration

Name	Role	Shares
JC Jasper Cornelius Kurth 1984	Managing Director/CEO	-

Board

Name	Role	Shares
MK Mimi Kristine Berdal 1959	Board Member	-
JA John Andersen 1967	Chairman	-
AU Ann Ulrika Gidner 1966	Board Member	-
TR Thomas Ramdahl 1956	Board Member	-
JG Jens Gisle Schnelle 1985	Board Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
B BDO AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
TB Tone Bjørseth-Andersen 1969	-	16.37 % indirectly
CB Celina Bjørseth-Andersen 1999	-	2.32 % indirectly
MB Marcus Bjørseth-Andersen 2003	-	2.32 % indirectly
BB Bjørseth-Andersen Benedicte 2006	-	2.32 % indirectly
JD Johan Diderik Cappelen 1988	-	2.21 % indirectly
BG Bård Gaute Bergfald 1970	-	2.21 % indirectly
CD Carl Diderik Cappelen 1955	-	1.54 % indirectly
JM Jon Magne Asmyr 1973	-	1.53 % directly
RF Richard Felix Heinrich 1983	-	1.38 % directly 0.34 % indirectly 1.04 %
CR Christian Ringnes 1954	-	1.16 % indirectly

Last update: May 14, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
S SCATEC INNOVATION AS	NO0010597883	64,417,932	22.97 %
R ROHT INVEST AS	NO0010597883	11,794,640	4.2 %
B BRENNEBU AS	NO0010597883	10,532,567	3.76 %
N NORTH ENERGY ASA	NO0010597883	8,000,000	2.85 %
B BERGFALD HOLDING AS	NO0010597883	6,200,000	2.21 %
BA Bank Ab Nordnet	NO0010597883	4,710,130	1.68 %
JM Jon Magne Asmyr 1973	NO0010597883	4,300,000	1.53 %
D DNB BANK ASA	NO0010597883	4,255,892	1.52 %
N NORDNET LIVSFORSIKRING AS	NO0010597883	3,714,806	1.32 %
S SCATEC INVEST IV AS	NO0010597883	3,165,920	1.13 %
O OLILI AS	NO0010597883	2,910,000	1.04 %
BA Bank As Danske	NO0010597883	2,153,479	0.77 %
S SCIENCONS AS	NO0010597883	2,000,000	0.71 %
J JOL DRIFT AS	NO0010597883	1,815,781	0.65 %
S SCATEC INVEST II AS Closed	NO0010597883	1,584,324	0.56 %
B BÆKKELAGET HOLDING AS	NO0010597883	1,538,543	0.55 %
EK Eivind Kjellman Opedal 1960	NO0010597883	1,513,500	0.54 %
A ARNE HELLESTØ AS	NO0010597883	1,416,021	0.5 %
M MIDDELBOE AS	NO0010597883	1,405,758	0.5 %
BA Bank As Saxo	NO0010597883	1,177,396	0.42 %
AF Arne Fredrik Hellestø 1950	NO0010597883	1,080,566	0.39 %
JP Jan-Tore Pedersen 1951	NO0010597883	1,002,099	0.36 %
O OLAV OLSEN HOLDING AS	NO0010597883	1,000,000	0.36 %
W WORKPARTNER AS	NO0010597883	989,163	0.35 %
RF Richard Felix Heinrich 1983	NO0010597883	965,617	0.34 %
A ABDALY SPESIALIST ALLMENNMEDISIN AS	NO0010597883	915,440	0.33 %
GF Gunnar Freberg 1955	NO0010597883	881,000	0.31 %
S SLOTTSFJELL INVEST AS	NO0010597883	846,000	0.3 %
TE Tor Edmund Klepp 1953	NO0010597883	800,000	0.29 %
S SAUAR INVEST AS	NO0010597883	792,941	0.28 %
SA Sharam Alghasi 1965	NO0010597883	783,700	0.28 %
CB Clearstream Banking S.a.	NO0010597883	743,565	0.27 %
AS Astrid Solesvik 1970	NO0010597883	729,000	0.26 %
HR Henning Reier-Nilsen 1944	NO0010597883	708,916	0.25 %
A ALLEGRO AS	NO0010597883	700,546	0.25 %
BL Bjørn Lund 1949	NO0010597883	700,220	0.25 %
M MUST INVEST AS	NO0010597883	700,000	0.25 %
O OCOBIAM AS	NO0010597883	652,000	0.23 %
A AHLBOM HOLDING AS	NO0010597883	642,801	0.23 %
O OPTIPOS AS	NO0010597883	627,114	0.22 %
CS Christian Sortland 1986	NO0010597883	571,905	0.2 %
R REARDEN AS	NO0010597883	563,712	0.2 %
KA Karsten Andre Helland 1976	NO0010597883	563,538	0.2 %
TR Thomas Raa 1990	NO0010597883	558,559	0.2 %
L LUCELLUM AS	NO0010597883	550,000	0.2 %
KØ Kjell Øivind Hansen 1947	NO0010597883	549,000	0.2 %
FB Frode Brudeskar Talstad 1975	NO0010597883	545,000	0.19 %
I INVEN2 AS	NO0010597883	541,247	0.19 %
SN Stig Nytrøen 1969	NO0010597883	515,175	0.18 %
JS Johnny Silberg 1940	NO0010597883	500,000	0.18 %
BA Bank Abp Nordea	NO0010597883	495,370	0.18 %
S SANDE LEGESENTER EIENDOM DA	NO0010597883	490,970	0.18 %
LS Ludvik Sandnes 1949	NO0010597883	486,489	0.17 %
R RO INVEST AS	NO0010597883	450,000	0.16 %
A ABC INVEST AS	NO0010597883	446,759	0.16 %
MS Morgan Securities Plc Jp	NO0010597883	434,385	0.15 %
AS Arnfinn Stakston 1966	NO0010597883	424,000	0.15 %
K KT GLOBAL INVEST AS	NO0010597883	419,454	0.15 %
MK Mimi Kristine Berdal 1959	NO0010597883	416,990	0.15 %
MS Marit Skjerven 1959	NO0010597883	412,000	0.15 %
R RAKKARBERGET AS	NO0010597883	400,000	0.14 %
ES Egil Sørvær Sven 1988	NO0010597883	395,662	0.14 %
M MULTITAINMENT AS	NO0010597883	390,000	0.14 %
OH Ove Husebø 1962	NO0010597883	390,000	0.14 %
MA Martin Aanonsen 1955	NO0010597883	380,000	0.14 %
SJ Steinar Jordbakke 1977	NO0010597883	367,734	0.13 %
TB The Bank Of New York Mellon Sa/Nv	NO0010597883	353,185	0.13 %
T TRACK AS	NO0010597883	350,364	0.12 %
H HERØY GLASS OG GAVE AS	NO0010597883	350,000	0.12 %
P PINGVIN INVEST AS	NO0010597883	344,996	0.12 %
G GRINDØY AS	NO0010597883	340,083	0.12 %
BA Bank Ab Avanza	NO0010597883	336,550	0.12 %
JC Jorge Consepcion Ramos Cuadra 1958	NO0010597883	324,841	0.12 %
TD Thomas Dørum 1977	NO0010597883	304,000	0.11 %
R ROLF ANDREASSEN AS	NO0010597883	303,571	0.11 %
B BASIC I AS	NO0010597883	300,000	0.11 %
TA Torleif Andersen 1959	NO0010597883	295,000	0.11 %
SO Svenn Ove Hafstad 1958	NO0010597883	294,000	0.1 %
BM Bjørn Martin Tollefsen 1958	NO0010597883	285,000	0.1 %
OH Ole Henrik Sten Johansen 1997	NO0010597883	282,000	0.1 %
LM Lars-Petter Moe 1966	NO0010597883	281,932	0.1 %
TV Tore Vangstad 1969	NO0010597883	280,000	0.1 %
NC Na Citibank	NO0010597883	277,303	0.1 %
TT Tage Tveit Gustavsen 1975	NO0010597883	274,194	0.1 %
TH Thor Henrik Johansen 1981	NO0010597883	264,600	0.09 %
TS Tore Strand 1968	NO0010597883	260,010	0.09 %
EH Edvard Heir 1986	NO0010597883	254,628	0.09 %
B BRENDESKARET AS	NO0010597883	251,000	0.09 %
JE John Egil Bull Skadberg 1951	NO0010597883	250,000	0.09 %
AA Arash Abdolkarimi Nejad 1973	NO0010597883	245,634	0.09 %
LP Lynch Pierce Fenner Sm Merrill	NO0010597883	241,279	0.09 %
ES Edvard Stordahl 1981	NO0010597883	240,000	0.09 %
TB Tina Bjørnlund Bønsdorff 1971	NO0010597883	234,781	0.08 %
BS Børge Solberg 1968	NO0010597883	232,500	0.08 %
CC Carl Christian Ovart Ashton Johnsen 1973	NO0010597883	230,370	0.08 %
TM Tore Myrvold 1971	NO0010597883	225,000	0.08 %
S STEINAR SÆLID AS	NO0010597883	220,880	0.08 %
FR Finn Roger Døvig 1953	NO0010597883	213,997	0.08 %
SR Svein Romdal 1969	NO0010597883	213,799	0.08 %
RB Roar Brauti 1962	NO0010597883	211,596	0.08 %

Shares owned by the THOR MEDICAL ASA

Name	Share class	Total number of shares	Share
T TM TECHNOLOGIES AS	Ordinary shares	641,732	100 %

Last update: Jun 2, 2025

Group structure

THOR MEDICAL ASA
Total operating income 2024: NOK 0
Operating profit 2024: NOK -41,946,000
Employees: 17

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Annual Total Result	-40,593,000	-2,855,000	-310,251,000	-433,151,000
Total assets	363,926,000	278,406,000	95,301,000	281,528,000
Total liabilities	22,462,000	3,777,000	42,079,000	151,189,000
Total equity	341,463,000	274,629,000	53,222,000	130,339,000

P&L

Year	2024	2023	2022	2021
Total operating income	0	0	0	0
Total operating costs	41,946,000	4,356,000	325,323,000	445,164,000
Operating result	-41,946,000	-4,356,000	-325,323,000	-445,164,000
Financial income/costs	1,353,000	1,501,000	15,179,000	12,149,000
Profit before tax	-40,593,000	-2,855,000	-310,144,000	-433,015,000
Total tax & extraordinary income/cost	0	0	107,000	136,000
Annual Total Result	-40,593,000	-2,855,000	-310,251,000	-433,151,000

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	234,847,000	234,728,000	674,000	6,080,000
Total current assets	129,079,000	43,678,000	94,627,000	275,448,000
Total assets	363,926,000	278,406,000	95,301,000	281,528,000
Short term debt	22,462,000	3,777,000	42,079,000	151,189,000
Long term debt	0	0	0	0
Total liabilities	22,462,000	3,777,000	42,079,000	151,189,000
Contributed capital	400,204,000	292,777,000	55,624,000	162,491,000
Retained earnings	-58,741,000	-18,148,000	-2,402,000	-32,152,000
Total equity	341,463,000	274,629,000	53,222,000	130,339,000
Total equity and liabilities	363,925,000	278,406,000	95,301,000	281,528,000

Classification

21st company classification

BETA

Small company

Type of organization

Public limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

THOR MEDICAL ASA994 297 422

THOR MEDICAL ASA

Links

Organization

Ownership

Financials

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Shares owned by the THOR MEDICAL ASA

Group structure

Financials

Summary

P&L

Balance overview

Classification